Loading...
Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?
BACKGROUND: Two strategies for prevention of upper gastrointestinal (UGI) events for non-selective (ns)NSAID users are replacement of the nsNSAID by a cyclo-oxygenase-2-selective inhibitor (coxib) or co-prescription of a gastroprotective agent (GPA). AIM: To identify whether and in whom either of th...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3687334/ https://ncbi.nlm.nih.gov/pubmed/23710837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12348 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|